Gemmus Pharma

Gemmus Pharma is a developer of therapeutic drugs aimed at treating influenza and other infectious diseases. The company's therapeutic drugs include GP1681, a non-peptide eiconsanoid analog used to treat influenza infections requiring hospitalization, either as a standalone treatment or in combination with antiviral drugs such as oseltamivir, enabling patients to begin treatment more quickly and leading to better medical outcomes.